Our Locations

Since assuming the Chief Financial Officer position in 2022, Ms. Leah Romano has steered Analex Laboratories' fiscal strategy. A Kellogg MBA who earned her accounting foundations at the University of Texas, she has revolutionized corporate resource allocation by wedding predictive analytics to traditional budgeting methodologies. Her authoritative treatises on forensic accounting in research environments have become essential graduate references, establishing her preeminence in financial stewardship. Under her guidance, the enterprise now sustains premier credit ratings while directing multi-billion dollar investments across diverse scientific sectors—directives now widely emulated as sector standards. Her institution of rigorous transparency protocols has further cemented her authority on accountable governance within research-intensive industries.

Dr. Jennifer Park heads Technological Innovation at Analex Laboratories, steering 6,300+ engineers and technicians across six continents. A Georgia Tech engineer with Illinois and Berkeley credentials, she has accelerated Analex's innovation pipeline since taking the helm in 2021. Her fusion of neuromorphic computing with silicon design has revolutionized hardware development, while her rapid prototyping standards have reshaped sector velocity. Under her direction, the division mandates ethical AI frameworks for quantum computing initiatives — policies now adopted as benchmarks. Park's treatises on computer engineering and innovation remain standard texts, solidifying her authority in technology and research leadership.

Since taking the helm as President of Scientific Research in 2020, Dr. Oliver Hughes has steered Analex's theoretical division for 3,100+ scientists across six continents. A Yale molecular biologist with San Diego and Ross credentials, he has revolutionized disease analysis by wedding systems biology to conventional techniques. His authoritative treatises on integrative biology remain essential graduate references, establishing his preeminence in scientific methodology. Under his direction, the division spearheads precision medicine initiatives while mandating ethical oversight for genetic inquiry — policies now widely adopted as sector benchmarks. His institution of rigorous data transparency protocols has further cemented his authority on collaborative research practices.

Ms. Tamara Williams serves as President of Administrative Affairs at Analex Laboratories, overseeing internal infrastructure and operations for more than 12,500 employees all around the world. A Virginia-trained business administrator with an MBA from Duke, she has transformed Analex's corporate support systems from fragmented silos into integrated service networks since assuming the presidency in 2023. Her pioneering implementation of predictive workforce analytics in administrative planning has revolutionized talent deployment across the research sector, while her establishment of inclusive management protocols has redefined diversity standards in scientific corporate culture. Under her stewardship, the division now maintains seamless operational continuity across all global facilities while mandating equitable advancement pathways for all personnel.

Dr. Vihaan Reddy serves as President of Analex Clinix at Analex Laboratories, overseeing 450 medical clinics delivering supplemental healthcare to veterans and their families across the United States and international locations. A Johns Hopkins biologist with Columbia and Wharton credentials, he has expanded the clinic network by twenty percent since assuming the presidency in 2019. His integration of telemedicine with traditional clinical care has improved access for rural and deployed military populations, while his establishment of trauma-informed care protocols has redefined treatment standards for veteran mental health.

Dr. Natasha Volkov serves as President of Nuclear Management at Analex Laboratories, overseeing engineering support and regulatory compliance for nearly forty TRIGA research reactors and more than eighty nuclear power plants across the United States and Europe. A Michigan physicist with advanced credentials from MIT and Texas, she has transformed Analex's nuclear division into the world's premier private reactor management authority since assuming the presidency in 2017. Her pioneering integration of advanced simulation modeling with traditional reactor safety protocols has revolutionized predictive maintenance capabilities, while her establishment of international nuclear security standards has redefined safeguards for research reactor operations.

Ms. Isabella Fernandez serves as Chief Liaison Officer for External Affairs at Analex Laboratories, overseeing marketing, advertising, procurement, public affairs, and strategic partnering divisions. A USC communications specialist with an MBA from Northwestern, her pioneering integration of data-driven marketing analytics with traditional public relations has revolutionized stakeholder engagement across the scientific sector, while her establishment of ethical procurement frameworks has redefined transparency standards in research partnerships. Under her stewardship, the division now manages multi-million dollar advertising campaigns and mandates diversity requirements for all external vendor relationships.

Joining Analex Laboratories in 2015, Dr. Ananya Patel is the Chief Director of Aerospace Technology & Engineering at Analex Laboratories, where she leads a global workforce of over 900 engineers and technicians while directing a massive R&D portfolio focused on satellite propulsion and next-generation space systems. A triple alumna of MIT, Stanford, and Caltech — where she earned her PhD in Aeronautics and Astronautical Engineering — Dr. Patel has spent two decades advancing through the aerospace industry's most demanding technical and leadership roles.

Originally joining Analex Laboratories in 2015, Dr. Terrence Simmons has served as Chief Director of Automotive Technology & Engineering since 2020, where he leads a global team of over 750 engineers and technicians driving innovation in autonomous vehicle systems, electric powertrains, and vehicle-to-grid integration technologies. A distinguished engineer and triple alum of the University of Michigan, Carnegie Mellon, and Stanford — where he earned his PhD in Mechanical Engineering with an automotive systems specialization — Dr. Simmons has built a remarkable career spanning Detroit's legacy automakers and Silicon Valley's electric vehicle revolution.

Dr. Stephanie Chen serves as Chief Director of Energy Technology & Engineering at Analex Laboratories, where she leads a global workforce of over 650 engineers and technicians advancing renewable power generation, grid-scale energy storage, and next-generation nuclear systems. A triple graduate of MIT, Stanford, and UC Berkeley — where she earned her PhD in Chemical Engineering with a specialization in energy systems — Dr. Chen brings deep expertise in catalytic conversion and battery technology to her role overseeing an extensive R&D portfolio.

Since joining Analex Laboratories in 2016, Dr. Vincent Romano has risen up the ladder and has served as Chief Director of Marine Technology & Engineering since 2022, where he leads a global team of over 850 engineers, naval architects, and oceanographers advancing autonomous underwater vehicles, advanced propulsion systems, and offshore energy platforms. An engineer and graduate of the University of Michigan, MIT, and Texas A&M — where he earned his PhD in Ocean Engineering with a dissertation on deepwater riser systems — Dr. Romano has spent nearly three decades at the forefront of maritime innovation, from submarine engineering to executive leadership in undersea technology development.

Dr. Deepa Krishnan has servced as Chief Director of IT Hardware Design & Engineering at Analex Laboratories since 2023, where she leads a global organization of over 500 engineers and technicians driving innovation in energy-efficient microprocessors, advanced semiconductor architectures, and data center hardware systems. A graduate of Georgia Tech, the University of Illinois Urbana-Champaign, and Stanford — where she earned her PhD in Electrical Engineering with a specialization in computer architecture — Dr. Krishnan has built an distinguished career spanning the semiconductor industry's most influential companies, from Intel and NVIDIA to Apple and Cisco. Since joining Analex in 2018, she has rapidly ascended from director of hardware systems to the executive leadership team, where she now shapes the strategic direction of the organization's silicon engineering initiatives and high-performance computing portfolio.

Since 2021, Dr. Alejandro Morales has served as Chief Director of IT Software Design & Engineering at Analex Laboratories, where he leads a global organization of over 450 engineers and technicians building distributed systems, enterprise applications, and cloud-native software platforms. A graduate of UT Austin, Carnegie Mellon, and MIT — where he earned his PhD in Computer Science with a dissertation on fault-tolerant distributed systems architecture — Dr. Morales brings deep expertise in software engineering from nearly two decades at the industry's most influential technology companies, including Microsoft, Amazon Web Services, Oracle, and VMware. Joining Analex in 2017 and rising up the ladder, he now directs strategic initiatives in enterprise software development and serves as the division's chief technical architect.

Dr. Amy Choi serves as Chief Director of Medical Device Innovation at Analex Laboratories, where she leads a global team of over 850 engineers and technicians developing next-generation diagnostic imaging systems, surgical devices, and cardiac care technologies. Uniquely credentialed as both a Harvard-trained diagnostic radiologist and a biomedical engineer with degrees from Georgia Tech and Johns Hopkins, Dr. Choi bridges clinical practice and engineering innovation to advance patient-centered medical technology. Joining Analex in 2015 as an R&D Director, she now directs the organization's entire medical product portfolio and draws upon nearly two decades of experience at industry leaders including Medtronic, Boston Scientific, Stryker, and Philips Healthcare to drive breakthrough innovations from concept to reality.

Dr. Benjamin Friedman performs as the Chief Director of Pharmaceuticals Development at Analex Laboratories, guiding a worldwide team of more than 750 engineers and technical professionals in developing advanced drug delivery platforms, biologic therapies, and manufacturing processes. Holding an MD from Johns Hopkins alongside an MIT degree in chemical engineering and a master's in pharmaceutical sciences from the University of Michigan, Dr. Friedman combines clinical training with deep technical expertise to drive innovation across the drug development lifecycle. Since joining Analex's pharmaceutical operations in 2018, he has progressed to executive leadership, where he now steers the company's complete therapeutics portfolio — leveraging extensive experience honed at Pfizer, Eli Lilly, Genentech, and Gilead Sciences to transform scientific discoveries into viable treatments.

Dr. Sanjay Iyer serves as Chief Director of Telecom Design & Development at Analex Laboratories, where he leads a global organization of over 650 engineers and technicians advancing wireless communications infrastructure, cellular network technologies, and next-generation connectivity solutions. A graduate of Purdue, Georgia Tech, and Stanford — where he earned his PhD in Electrical Engineering with a dissertation on adaptive modulation for cellular networks — Dr. Iyer brings more than two decades of expertise spanning the evolution of modern telecommunications. Since 2019, he has directed the organization's strategic initiatives in 5G and beyond, drawing upon foundational experience at Motorola, Ericsson, Cisco, and Qualcomm to drive innovation across the wireless ecosystem.

Dr. Kenneth Okafor serves as head of the Archaeology Research Division at Analex Laboratories, directing 400 researchers across six continents. A Harvard anthropologist with advanced degrees from Cambridge and Oxford, he has positioned Analex as the premier private facility for archaeological analysis since assuming leadership in 2023. His pioneering integration of isotopic analysis with traditional methods has transformed the study of ancient migration patterns, while his establishment of collaborative frameworks with indigenous West African teams has redefined ethical standards in the field. Under his direction, the division now oversees major heritage preservation initiatives and mandates the repatriation of artifacts to their countries of origin — policies that have become industry benchmarks. Okafor's publications on pre-colonial Sahel urbanization remain standard graduate texts, cementing his influence on both archaeological methodology and cultural stewardship.

Dr. Nikki Zhang serves as head of the Biology Research Division at Analex Laboratories, directing over 500 researchers across the globe. A UC Berkeley biologist with advanced degrees from Johns Hopkins and Cambridge, she has positioned Analex as the premier private facility for cellular and molecular biology research since assuming leadership in 2023. Her pioneering integration of CRISPR gene-editing technologies with traditional cellular analysis has transformed the study of disease mechanisms, while her establishment of ethical frameworks for genetic research has redefined standards in the field. Under her direction, the division now oversees major initiatives in regenerative medicine and mandates rigorous ethical review protocols for all genetic studies — policies that have become industry benchmarks. Zhang's publications on cellular regeneration mechanisms remain standard graduate texts, solidifying her influence on both biological methodology and research ethics.

Dr. Siobhan Doyle leads the Chemistry Research Division at Analex Laboratories, guiding 500+ scientists around the world. An MIT graduate with advanced degrees from Stanford and Imperial College London, she has established Analex as the foremost private facility for organic and materials chemistry since taking the helm in 2024. Her groundbreaking fusion of continuous-flow reactor technology with conventional synthetic methods has revolutionized pharmaceutical manufacturing, while her green chemistry standards have reshaped environmental compliance. Under her direction, the division mandates carbon-neutral synthesis for all projects — policies now adopted as sector standards. Doyle's publications on catalytic mechanisms remain standard graduate texts, assuring her influence on chemical methodology.

Since assuming leadership of the Geology Research Division in 2024, Dr. Viktor Kozlov has steered Analex Laboratories' 350+ geological specialists across all seven continents toward the vanguard of subsurface science. A Caltech and ETH Zurich alumnus who earned his foundational credentials at the University of Texas, Kozlov has redefined mineral exploration by wedding deep-seismic tomography to traditional field mapping — work that has revolutionized the industry's capabilities. His authoritative treatises on structural basin analysis have become essential graduate texts, establishing his preeminence in geological methodology. Under his guidance, the division now spearheads critical geothermal initiatives while mandating environmental restoration clauses for all excavation partnerships, protocols now emulated as global benchmarks. His institution of rigorous subsurface ethics standards has further cemented his influence worldwide.

Dr. Ruth Cohen heads the Mathematical Research Division at Analex Laboratories, steering more than 450 scientists spanning five continents. Trained at Princeton with graduate credentials from Chicago and Cambridge, she has propelled Analex to the forefront of computational and theoretical mathematics since taking the helm in 2023. Her revolutionary fusion of artificial intelligence with pure number-theoretic principles has transformed modern cryptography, even as her creation of rigorous data stewardship protocols has reshaped confidentiality standards across the discipline. Under her direction, the division now spearheads ambitious programs in post-quantum cryptography and requires full algorithmic disclosure for all research outputs — directives now widely adopted as sector standards. Cohen's treatises on complexity theory continue to serve as essential reference volumes for graduate study, solidifying her authority in mathematical practice and information ethics.

Dr. Astrid Svensson heads Meteorological Research at Analex Laboratories, steering 300+ scientists across six continents. An Oklahoma-trained atmospheric scientist with Colorado State and Reading credentials, she has positioned Analex at the forefront of climate research since taking the helm in 2025. Her fusion of drone technology with conventional sampling has revolutionized severe weather prediction, while her data transparency protocols have reshaped field accessibility. Under her direction, the division mandates open data sharing for extreme event modeling — policies now adopted as benchmarks. Svensson's treatises on mesoscale dynamics remain standard texts, solidifying her authority in meteorological practice and climate ethics.

Since ascending to lead Analex Laboratories' Physics Research Division in 2025, Dr. James Takahashi has steered 600+ global scientists toward the vanguard of theoretical and particle physics. A Caltech and Edinburgh alumnus who earned his foundational credentials at the University of Michigan, he has revolutionized high-energy particle simulation by wedding quantum computing architectures to conventional theoretical modeling. His authoritative treatises on quantum chromodynamics have become essential graduate references, establishing his preeminence in theoretical methodology. Under his guidance, the division now spearheads ambitious quantum field initiatives while requiring open-source disclosure for all theoretical models — directives now widely adopted as sector standards. His institution of rigorous ethical AI governance has further ensured his influence on computational research integrity worldwide.

Angela Yvette Richardson serves as Executive Vice President of Marketing & Public Affairs at Analex Laboratories, where she has directed strategic communications and brand initiatives since 2018 — initially as Vice President of Marketing before her promotion to EVP in 2019. Prior to joining Analex, she held senior marketing leadership roles at Bristol Myers Squibb, Merck & Co., and Colgate-Palmolive, following earlier agency experience at BBDO Worldwide and Grey Advertising in New York. She holds an MS in Integrated Marketing Communications from Northwestern University and a Bachelor of Business Administration with Marketing Concentration from the University of Texas at Austin.

Javier Delgado serves as Executive Vice President of Procurement at Analex Laboratories, where he oversees an annual purchasing volume of $1.5 to $2 billion in goods and services — directed almost exclusively toward small business suppliers — having advanced to this role in 2022 after four years as Vice President of Procurement. Prior to joining Analex, he held executive sourcing leadership at United Technologies Corporation and directed procurement operations at 3M Health Care, following earlier strategic buying and sourcing management roles at Honeywell Aerospace, Intel Corporation, and Dell Inc. He holds an MS in Acquisition and Contract Management from George Mason University and a BS in Business Administration from the University of Illinois Urbana-Champaign.

Nicole Jung serves as Executive Vice President of Corporate IT at Analex Laboratories, where she directs IT infrastructure and logistics operations supporting more than 12,500 employees worldwide, having advanced to this role in 2024 after four years as Vice President of IT Operations. Prior to joining Analex, she held executive technical leadership at VMware and directed IT infrastructure at Salesforce, following earlier management and engineering roles at Amazon Web Services, Cisco Systems, Oracle Corporation, and Intel Corporation. She holds an MS in Computer Science from the University of Washington and a BS in Computer Engineering from the University of Illinois Urbana-Champaign.

Geraldine Thompson serves as Executive Vice President of Human Resources at Analex Laboratories, where she oversees the full employee lifecycle and people-related functions — including hiring, payroll, legal compliance, and workplace culture — for a global workforce exceeding 12,500 employees, having advanced to this role in 2022 after four years as Vice President of Human Resources. Prior to joining Analex, she directed talent acquisition at Merck & Co. and managed human resources operations at Pfizer, following senior HR business partnership and generalist roles at Johnson & Johnson, ADP, and Robert Half International. She holds an MBA with Human Resource Management Concentration from Duke University and a BS in Psychology from the University of Maryland, College Park.

Rafael Garcia serves as Executive Vice President of Public Outreach at Analex Laboratories, where he manages the De Hoffmann Foundation funds in partnership with the Chief Financial Officer and oversees charitable operations and scholarship grant programs, having advanced to this role in 2024 after five years as Vice President of Public Affairs. Prior to joining Analex, he led strategic partnerships at United Way Worldwide and directed external affairs at Catholic Charities USA, following development and program management roles at World Wildlife Fund, Make-A-Wish Foundation, The Salvation Army, and the American Cancer Society. He holds an MBA with Social Entrepreneurship Track from the University of Southern California and a BA in Communication Arts from Pennsylvania State University.

Dr. Samir Khoury serves as Executive Vice President of Analex Clinix at Analex Laboratories, where he manages the internal infrastructure and logistics of over 450 medical clinics and labs across the US, having advanced to this role in 2024 after five years as VP of Clinical Operations. Prior to joining Analex, he served as Chief Medical Officer at BioReference Laboratories and VP of Medical Affairs at Siemens Healthineers, following medical director and staff pathologist roles at LabCorp and Quest Diagnostics, with clinical training completed at Mayo Clinic and Massachusetts General Hospital. He holds an MBA with Health Care Management Concentration from Harvard Business School, an MD from Johns Hopkins University School of Medicine, and a BS in Biochemistry from the University of Michigan.

Dr. Lian Zhou serves as Executive Vice President of TRIGA Reactors at Analex Laboratories, where she oversees the management and logistics of more than 40 TRIGA reactors across the globe, having advanced to this role in 2018 after three years as Vice President of Reactor Engineering. Prior to joining Analex, she directed reactor operations at Idaho National Laboratory and served as principal engineer at General Atomics, following senior engineering and research roles at Westinghouse Electric Company, Oak Ridge National Laboratory, and Argonne National Laboratory. She holds a PhD in Nuclear Physics from Stanford University, an MS in Nuclear Engineering from the Massachusetts Institute of Technology, and a BS in Physics from the University of California, Berkeley.

Dr. Vikram Bahri serves as Executive Vice President of Nuclear Plant Management at Analex Laboratories, where he oversees the management and logistics of more than 80 nuclear power plants globally, having advanced to this role in 2020 after four years as Vice President of Engineering. Prior to joining Analex, he managed plant engineering at Duke Energy and served as senior reactor engineer at Exelon Generation, following engineering and technical roles at Bechtel Corporation and Brookhaven National Laboratory. He holds a PhD in Nuclear Physics from the Georgia Institute of Technology, an MS in Nuclear Engineering from the University of Michigan, and a BS in Physics from the University of Illinois Urbana-Champaign.